R-Tech Ueno Overview
- Founded
-
1989
- Status
-
Acquired/Merged
- Employees
-
80
- Latest Deal Type
-
PIPE
- Latest Deal Amount
-
$10M
R-Tech Ueno General Information
Description
Developer of pharmaceuticals intended to develop solutions for unmet medical needs. The company is a Japanese pharmaceutical company that manufactures AMITIZA for Sucampo and Sucampo's commercialization partners, enabling its clients with research and development, manufacturing and marketing of drugs, development support, and contract manufacturing services.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Office
- NBF Hibiya Builing 10th Floor
- 1-1-7 Uchisaiwaicho Chiyoda-ku
- Tokyo, 100-0011
- Japan
R-Tech Ueno Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. PIPE | 22-Oct-2015 | $10M | 0000 | 000.00 | Completed | Profitable |
| 3. Merger/Acquisition | 13-Oct-2015 | 00000 | 00000 | Completed | Profitable | |
| 2. IPO | 01-Mar-2008 | Completed | Profitable | |||
| 1. Early Stage VC | Completed | Profitable |
R-Tech Ueno Patents
R-Tech Ueno Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170020890-A1 | Pharmaceutical composition comprising fatty acid derivative | Inactive | 19-Jun-2015 | 0000000000 | |
| JP-2018080114-A | Anti-human vap-1 monoclonal antibody | Pending | 29-May-2015 | 000000000 | |
| JP-2016222563-A | Ophthalmological composition for treating pigmentary degeneration of retina | Pending | 28-May-2015 | ||
| JP-2018080113-A | Treatment agent of cerebral infarction | Pending | 27-May-2015 | 0000000000 | |
| JP-2014114279-A | Combination of therapeutic agents for ophthalmology which enhances effect of agent with binding affinity to albumin in aqueous humor | Active | 13-Nov-2012 | 0 |
R-Tech Ueno Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Ryuji Ueno Ph.D | Co-Founder |
R-Tech Ueno Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
R-Tech Ueno Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Nissay Capital | Venture Capital | Minority | 000 0000 | 000000 0 |